2026 Hybrid US Bioassay Conference
10th Annual | College Park, Maryland, USA | March 23-26, 2026
College Park Marriott Hotel & Conference Center
Registration Late Prices:In-person registration closes end-of-day March 13, 2026.
3-Day Event
(In-Person Only)
March 24-26, 2026
Includes:
- FDA-lead Workshop
- Full-Day Bioassay Workshops
- Scientific Poster Session
- FDA Roundtable discussions
- Two days of Podium Presentations
- Two networking events
2-Day Event
(In-Person or Virtual)
March 25-26, 2026
Includes:
- FDA Roundtable discussions
- Two days of Podium Presentations
- One networking event
Event Add-On
Monday Statistical Workshop:
(In-Person or Virtual)
March 23, 2026
Includes:
- Full-Day Statistical Workshops
- Over 5 Industry Podium Presentations
- FDA Presentations & Panel Discussions
Group Discounts (only applicable to Industry tickets):
Quick Links
March 23-26, 2026
College Park, MD
Hybrid Conference
Deadlines
Abstract Submission: July 1, 2025
Poster Submission: March 3, 2026
Registration Closes:
In-person closes March 13, 2026
Virtual closes March 20, 2026
Draft Agenda
Click below to view the draft agenda for our Hybrid 2026 US Bioassay Conference! Check the agenda for updates as we finalize our schedule.
Participating Companies:
- US FDA
- Biogen
- NIST
- Sanofi
- Lonza
- Eli Lilly and Company
- Organogenesis
- Iovance
- Autolus Therapeutics
- Charles River Laboratories
- Promega Corporation
- acCELLerate
- Agilent
2026 USB Exhibitors
2026 Planning Committee
Spencer Alford
Kala Bio
Sangeet Lal
4D Molecular Therapeutics
Pierre Lebrun
Cencora Pharmalex
Laureen Little
BEBPA
Mike Merges
Autolus Therapeutics
Nancy Niemuth
Act Two Consulting
Mike Sadick
Retired
Anton Stetsenko
BioQual Consulting
Perceval Sondag
Sanofi
Steven Walfish
Iovance